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Highlights: 
 
 -Medical travel is expanding rapidly around the world. 
 -There is still no overarching framework for policies related to medical travel. 
 -Experiment tested preferences considering factors based on existing evidence. 
 -Quality of care is the most critical factor in medical travel decision. 
 -A comprehensive framework based on all findings and available evidence is proposed. 
 
 
Abstract 
Global medical travel has had an increasing trend without a comprehensive, evidence-driven 
policy to ensure safe and effective practice. To identify key factors that influence medical travel, 
a series of studies culminating with a preference and decision-making component of over 500 
prospective medical travelers from a number of countries. Results indicated that quality of care 
was the most critical factor in the decision, followed by lower costs of procedure and shorter 
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waiting times. Lower costs were less of a factor if the procedure was more invasive, which also 
increased the importance of waiting time in the decision. The most desired destinations for care 
were in Europe (United Kingdom, Germany) and North America (United States). Building on these 
insights and previous literature, we present a model that for implementing applications from these 
factors and additional insights generated across the series of studies toward an effective policy 
framework.  
Keywords: medical travel, global health policy, medical tourism, health economics, 
evidence-based policy 
 
 
 
 
1. Introduction 
1.1 Current State of Medical Travel Policy 
Medical travel is the selective movement of patients beyond national borders to pursue 
medical treatment [1], representing a steadily growing sector in the global healthcare market. 
Strictly speaking, the specific concept of medical travel includes any treatment or procedure that 
a health professional deems necessary for maintaining patient quality of life. Using this framework, 
as opposed to medical tourism or simply receiving unplanned care while abroad, medical travel 
does not encompass emergency or life-threatening conditions, controversial treatment or medical 
tourism, where patients travel for non-urgent purposes that are of arguable necessity (e.g. cosmetic 
surgery, [2]).  
The magnitude at which individuals travel specifically for the purposes of urgent care is 
hard to accurately determine [3]. Estimates indicate that there are millions of medical travelers 
worldwide [2], with a market value of billions of U.S. dollars [4], where hospitals in at least thirty 
different countries are actively promoting the enterprise [5] in a highly unregulated market. A more 
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systematic attempt at regulating medical travel was carried out in EU, where the Directive 
2011/24/EU on the application of patients’ rights in cross-border healthcare was created by the 
European Parliament and Council [6] and implemented by member states [7]. The Directive 
defines conditions under which a patient may travel to another EU country for medical services 
and receive reimbursement, and it obliges the member states to provide the patient with all the 
necessary information via national contact points. However, it lacks sufficient binding mechanisms 
regulating the cross-border sharing of patient records, as well as ensuring a safe process, and a 
quality transition to follow-up care. 
1.2 Challenges in medical travel 
Research on medical tourism, which includes travel for cosmetic and non-urgent care, has 
mentioned this lack of regulation [8], yet few papers until recently have outlined specific needs for 
establishing guidelines specifically focused on medical travel. When discussed, important 
considerations have included: establishing international quality standards [9], economic and legal 
issues [10], information provided by medical travel agency websites [11], as well as several aspects 
regarding patient safety through the transfer of medical records, transparency of the care process, 
and safe choice [12].   
Medical travelers often aim to avoid undertaking certain medical procedures in their home 
country, due to the perception that they are unaffordable or unavailable [3]. As such, they should 
be considered as conscious consumers [13]. Making clear policy frameworks will thus go a long 
way in supporting safe and appropriate decisions.  
1.3 Factors Influencing Medical Travel Decisions 
To manage and regulate this phenomenon better, it is crucial to understand why individuals 
engage in medical travel. Known factors that may enhance or decrease the willingness of 
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individuals to travel for medical purposes and include quality of care, costs, and waiting time or 
the type of medical procedure under consideration [14]. While there have been attempts to model 
these factors using frameworks for a range of relevant drivers [6], significant interactions between 
those factors were left unexplored. For example, there is limited understanding about the 
interdependencies between decision-making factors and perceptions about the location of care [2, 
13]. 
The lack of insight into this decision-making process is problematic and can result in 
misleading claims from host clinics seeking to appeal to prospective patients. Focusing on the offer 
of reduced costs or waiting time, some individuals overlook the quality of the service provided 
[15], resulting in health risks. Medical travelers may also face a potential lack of medical follow 
up after returning home, even for those countries that do have international care frameworks in 
place [12]. 
Considering the evidence available in light of the patterns of behavior as well as challenges 
presented, a multi-year study covering multiple key aspects of medical travel was carried out by a 
large team of researchers from a number of countries (predominantly from Europe and North 
America) [1, 9, 10, 11, 12, 14, 16, 17]. The largest of these studies involved a sophisticated 
decision-making instrument for assessing likelihood of travel that would have the potential to 
inform policy through validating the strongest predictions of behavior. The following study 
presents a comprehensive model of insights from those data, and interprets for potential 
applications to policy.  
2. Methods 
2.1 Participants 
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Prospective medical travelers (n=529; 68% female; mean age 27.6 years, SD=10.4) were 
recruited for the study by using social media sites. A broad definition of potential medical travelers 
was used to include any individuals who belong to a non-patient population, or are yet to decide 
whether they would travel for medical care. Unfortunately, it was not possible to track the entry 
point used to access the study, but most circulation was carried out on Facebook and LinkedIn. 
Other sites used included ResearchGate and group mailing lists.    
The sample was predominantly European (87.7%) and 74.5% had at least a bachelor-level 
degree (or equivalent) or above. Sample characteristics are further detailed in a previous 
publication [14], though some participants considered in prior analyses were excluded in this 
particular model. Participants gave explicit informed consent prior to their participation. Ethical 
approval was granted from the Department of Engineering Ethics Committee at the University of 
Cambridge. Each participant was presented with six random scenarios combining the three 
domains, yielding a total of 3,174 observations.  
2.2 Measurement 
The corpus of available evidence regarding medical travel has predominantly involved data 
from past medical travelers, either studying the conditions under which medical travel occurs (e.g. 
[12, 2]), or the consequences of the medical processes [13]. Before promoting attempts to 
implement policies intended for entire populations, it is necessary to examine data regarding the 
general population (i.e., prospective medical travelers). 
To ensure appropriate aspects were included in the measure and in the analyses, a systematic 
literature search was conducted across PubMed and Europe PubMed Central databases. This built 
on the existing evidence review published in 2015 [1]. The articles that were considered in the 
review included the terms “medical travel” or “medical tourism” in their title or abstract, were 
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written in English, were published between January 1st, 2012 and April 15th, 2018. Articles 
produced by private firms that required a payment for access were excluded.   
The search yielded 253 hits overall, with a final number of 149, after excluding duplicates. 
Overall, 21 articles mentioned the number of medical travelers in any context (e.g. estimates of 
the overall number of medical tourists in the world), but only 10 articles included information 
about the number of medical travelers for specific destination countries. Overall, there were only 
minor adjustments to be included from the initial review: a slight increase in medical travelers in 
Turkey using 2011 data [18] and a fourfold increase in medical travelers to the Republic of Korea 
from 2014 data [19]. General factors of interest were not substantially different in the update 
review, reaffirming the choice of metrics and interpreted insights presented later.  
2.3 Instrument 
Existing accounts of patient choices have highlighted the benefits of studying individual 
behavior by presenting participants with hypothetical scenarios, followed by choosing whether or 
not to travel. These methods, known as stated preferences, act as reliable proxies for inferring 
future real behavior [20, 21]. We used a binary discrete choice experiment to capture patients’ 
stated preferences for medical travel [16]. 
To identify the main drivers of medical travel, a novel instrument based upon different 
combination of three domains was developed [14]. The domains were 1) invasiveness of procedure 
(i.e., hip and heart valve replacement); 2) reason for travel (i.e., fewer costs, shorter waiting lists, 
better quality of care); and 3) country of destination for a proposed medical procedure (namely 
Australia, Dubai, Germany, United Kingdom, Malta, New Zealand, Philippines, Portugal, Qatar, 
Singapore, Thailand and the United States of America). Additional individual features were also 
selected from existing literature [5, 3], encompassing four thematic blocks: sociodemographic 
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characteristics (i.e., sex, age, education level and income level); previous experience with medical 
travelling; time spent living abroad, and perception of local healthcare (i.e., own healthcare quality, 
cost and waiting times). These domains were selected according to literature reviews [1, 14]. 
Scenarios were constructed in such a way that each participant received six questions that 
combined procedure and reason levels, randomized by country [14]. This methodology was 
analogous to previously validated instruments applied in similar contexts [21]. Countries included 
in the option list were based on a linked literature review [1]. 
 
2.4 Statistical framework 
A multilevel logistic regression model was built to identify preferences for medical travel. 
Further justification for the use of such models can be found in the literature [16]. For multilevel 
logistic regression models, coefficients are relative measures of effect, known as odds ratio. To be 
considered significant at α <0.05, the confidence intervals must not include the value 1.0 (either 
both are above or both are below 1.0).  First-level variables included observations for individuals, 
including medical procedure and medical reasons, plus the additional questions regarding 
individual characteristics. For the second level of the model, observations were clustered around 
the country of destination. Variable coding and a rationale for the selection of the reference 
categories can be found in a previous publication [16]. In this case, multilevel modelling corrected 
the effect of each set of questions being encompassed by a single country, where responses given 
to the same country of destination were expected to be clustered.  
 
3. Results 
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Table 1 shows the results of multi-level logistic regression. Results of fixed parameters are 
presented at the top of this table, and results for random parameters are presented at the bottom of 
it. As seen, the majority of attributes were statistically significantly (α < .05) associated with the 
probability of a medical travel except the type of the medical need (heart valve vs. hip 
replacement), shorter waiting time (vs. fewer costs), the interaction of heart valve replacement and 
quality of care, income level ‘below poverty line’, income level ‘low’, education level ‘vocational 
school’, and sex (male vs. female). 
 
 
 
3.1 Drivers of Medical Travel 
Quality was the strongest predictor of choosing travel for medical care, followed by cost 
and waiting time. Specifically, the odds of medical travel were 3.93 times higher if the quality of 
the procedure was better, regardless of the procedure invasiveness. The effect of waiting lists and 
costs was dependent upon the urgency of the procedure. When individuals addressed situations 
including less invasive medical procedures (i.e., hip replacement), costs were as influential as 
waiting times. When the individuals were faced with a highly invasive procedure (i.e., heart valve 
replacement), medical travel was estimated to be 2.13 times more likely for shorter waiting times 
than for cost reductions.  
Demographic factors played an important role as medical travel drivers. Firstly, perception 
of home country health system influenced choices regarding medical travel. Specifically, if waiting 
time were shorter at home, the odds of choosing medical travel were 0.75. Similarly, the odds ratio 
(OR) was 0.36 if quality was perceived to be better at home than abroad. If costs were perceived 
as higher at home, odds for choosing medical travel were 1.30 Secondly, lower education level 
was significantly associated with increased probability of choosing medical travel. Individuals 
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who had only completed secondary school (OR 1.73) were more likely to travel compared to those 
who completed a Master’s degree or equivalent, though having a Bachelor degree or equivalent 
was associated with being less likely to choose travel (OR 0.44) using the same reference. Lastly, 
experience living abroad was an especially influential factor, as even short periods of time spent 
abroad (six months to 1 year) were associated with significantly increased likelihood of choosing 
the medical travel option (OR 3.57). 
 
3.2 Geographical Effects on Medical Travel 
Countries were ranked according to the probability that they were chosen as medical travel 
destinations (Table 2). Northern Europe (represented by the United Kingdom and Germany) and 
the United States arose as the most preferred choices. Southern Asia (represented by Thailand and 
Singapore) and the Middle East (represented by Qatar and Dubai) were less likely choices, and 
received lower perceived ratings of care, in line with previous findings [5]. As participants were 
not presented with all scenarios, the values in Table 2 reflect estimated percentages based on all 
responses, weighted by factors for each scenario in consideration of previous responses from 
individuals (see [16]). The values indicate the likelihood of choosing travel in a specific scenario 
after controlling for procedure, reason and the other socio-demographic variables, and not the total 
number of prospective medical travelers who would be willing to receive care in a given country.  
 
Note: Odds ratios are omitted as the estimation method can yield results above 100% and below 0%.  
For those who have travelled for care prior to completing the survey, though, South Asian countries 
were rated among the most popular destinations [1]. While stated preferences are typically 
considered reliable proxies, it is important to understand these as hypothetical preferences, noting 
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the possibility for social desirability or contextual factors influencing responses in the study versus 
real behaviors. 
4. Discussion 
This study demonstrated that quality, cost and waiting time are all influential factors in deciding 
whether to undergo a medical procedure abroad, which is in line with previous studies [8, 14]. 
Importantly, this study demonstrates that out of the three factors, quality of treatment plays the 
most critical role. Prospective medical travelers consider quality of received treatment as the 
utmost priority, however, there are currently no global regulations in place to ensure that receiving 
medical institutions adhere to adequate quality standards. 
At present, medical travel represents a highly unregulated market with informational and legal 
ambiguities. The model presented suggests that lower educational attainment is strongly associated 
with greater willingness to obtain medical treatment abroad. This presents a challenge as 
particularly the less-educated medical travelers might not be fully aware of risks associated with 
obtaining medical treatment abroad. A global action should be taken to reduce these ambiguities, 
and prospective medical travelers should be better informed about the multi-stage process of 
medical travel, and how each stage is linked to specific responsibilities, risks and benefits. This 
may perhaps be considered as a large-scale nudge, as it would not remove the option of traveling 
for care, but simply reduce the likelihood of unnecessary risks from limited information about the 
choices available. 
 Taking this composite model as well as the additional work cited into account, we propose a 
policy framework to improve patient safety and access to quality care. This is particularly in the 
context of responding directly to standing calls from the OECD for evidence to inform such a 
framework. Each point represents a key component for a full policy platform that should be in 
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place to ensure best practice, including evaluation of impacts. The proposed policy framework is 
merely a starting point, not a regulatory benchmark. The aim is to provide guidance to 
policymakers in increasing access to care on a global level and controlling the rapidly rising costs 
of medical treatment. We propose these to include: 
1. Binding quality standards as well as a mechanism for clear communication of such 
standards to all prospective patients. Standards should offer the ability to compare between 
locations of care and the home country. A universal standard is needed to establish relative 
differences. Any prospective host provider not meeting these standards should be 
transparent with that information for patients as well as third parties (e.g. insurers, health 
ministries).  
2. A publicly available repository of critical information accessible to prospective medical 
travelers, which should include clear advice for safely receiving care abroad, across the 
domains presented. This tool should gather key insights on prospective travelers for 
continual policy adaptation and sophistication. 
3. Secure, efficient, and standardized processes for sharing patient records between 
home and host providers should be mandatory. This should also consider the availability 
of information to patients. At present, several governmental initiatives exist to establish 
between-country agreements for medical travelers’ data sharing and financial coverage of 
health expenses abroad, however, these efforts are often in an early stage of partnerships 
[22, 23]. Singapore is a notable exception in this area, with a governmental initiative that 
facilitates sharing of patient records between public and private institutions for both local 
and foreign patients [24]. Some of these points are likely to be covered in Europe, where 
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General Data Protection Regulation guidelines will assist in formal application of 
standards. 
4. Economic and legal protections for patient groups, local health services, providers, and 
third-parties. Patients should be provided clear information on all related costs prior to 
choice and treatment. Hosting clinics must demonstrate what the effect of increased 
medical visitors will have on access and cost for locals. Providers should have fair warning 
of clear regulations regarding charges and liabilities linked to the timeline of care for each 
patient. Insurers and health ministries should have clear guidelines, limitations, and 
liabilities outlined in advance of any care received abroad. 
5. Appropriate boundaries and safeguards that support reasonable autonomy in patient choice. 
Policies should clarify to what extent they are applicable if patients go off-piste with 
choice, particularly related to treatment in clinics not meeting standards, and what 
implications this has on liability.  
6. Standard outcome measures that include indicators for recovery, all relevant timelines (i.e. 
waiting for treatment, treatment, admission length, inpatient rehabilitation, outpatient 
rehabilitation in country of care, and follow-up time after return to home country), cost 
comparisons, change in average costs in participating countries, and impact on clinical 
resources (i.e. doctors, nurses, administration) in participating locations.  
7. Specific provisions for adaptation of policies by workplace insurance and other likely third-
party actors. 
8. Clear definitions of any regulatory adaptations necessary for care for travelling or visiting 
patients (as opposed to those applied to local patients). 
AC
CE
PT
ED
 M
AN
US
CR
IPT
13 
 
9.  An agreed ‘ultimate’ outcome measure in global health policy should be established. In 
line with the WHO approach linked to the Health in All Policies agenda [25], we propose 
this to be a comprehensive measure of patient mental, physical, and social well-being [17]. 
 
These recommendations are neither absolute nor universally robust, but present key 
features that appear regularly in studies on this subject as well as in our own findings. Some may 
seem rather obvious, but based on the clear lake of awareness related to some standards and 
practices, we make them explicit for the sake of cogence. We strongly encourage all features be 
subject to further rigorous study, particularly from those organizations that have highlighted the 
potential of medical travel for impact on global health. 
4.1 Limitations 
Naturally, this study and the wider body of work from which it stems are subject to a 
number of limitations, most of which have been outlined in prior publication. Other concerns that 
could be addressed for more robust insights in future study would be to account for health systems 
in home countries versus those being considered for receiving care, particularly on how payment 
for services is handled.  
Critically, the nature of the sample and how they were initially engaged in the study raises 
understandable concerns about skew and bias. These relate specifically to access and entry points 
between different social media sites, as well as demographic distributions in the sample compared 
to European and North American populations. The technology to track access points is now widely 
available and would be helpful to monitor in future iterations. The sample was also highly educated 
and predominantly European, which may have a major influence on why lower education was a 
significant predictor of travel (less variability increasing impact of potential outliers, for example). 
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However, it may also be an indication of what people consider to be receiving care abroad. For 
instance, when it comes to assessing public services, particularly within the Schengen Area, it 
might be much harder to differentiate between countries than between continents. In these ways, 
conclusions presented may be considered speculative to a degree regarding how a broader 
population might choose. The basis for those changes (such as a more representative spread of 
incomes and access to private insurance) should certainly be controlled for in future adaptations 
of this study. 
Other limitations that could be addressed include lack of reliable information about 
participant health status such that it can be more useful in understanding treatment choices, as well 
as using a more narrow definition of medical travelers given the general population has a low 
probability of engaging in the option. Finally, further iterations of the model could consider all 
possible interactions, but given the factorial nature of such a model, we propose only doing so with 
an exponentially larger and more balanced sample.  
5. Conclusion 
In its present state, medical travel is a loosely – at least globally – regulated market of 
millions of individuals that lacks quality control and cannot guarantee legal and economic safety. 
The present work has contributed to the existing body of research of medical travel by providing 
insights about the decision-making of prospective travelers. Relying on empirical data on medical 
travel, this study introduced an evidence-based policy framework, providing a starting ground for 
the development of global health access policy. Addressing the nine specific actions outlined in 
the framework can improve access and decrease costs of medical travel, while ensuring the safety 
of patients, hospitals, and third-party providers. 
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Table 1.  
Multilevel model results: Parameter and error estimation for fixed (top) and random parameters 
and model fit statistics (bottom).  
Variable      Category Coefficients (CI) 
Fixed Parameters 
Individual level   
Intercept  4.71(1.82 – 12.17) ** 
Procedure    
 Heart valve replacement 1.00 (0.77 – 1.31) 
Reason   
 Waiting List 0.99 (0.76 – 1.30) 
 Quality 3.93 (2.91 – 5.33) ** 
Procedure x Reason   
 Heart valve replacement x Waiting list 2.13 (1.55 – 3.39) ** 
 Heart valve replacement x Quality 1.31 (0.85 – 2.02) 
Income   
 Below Poverty 0.64 (0.34 – 1.18) 
 Low 0.84 (0.61-1.16) 
 Above Average 0.67 (0.47-0.95) * 
 Very High 0.30 (0.14 – 0.63) ** 
Time Abroad   
 Between 6 months – 1 year 3.57 (2.56 - 4.98) ** 
 More than a year 7.18 (4.67 – 11.04) ** 
Rating of local healthcare   
 Waiting list 0.75 (0.63 – 0.90) * 
 Cost 1.30 (1.10 – 1.54) * 
 Quality 0.64 (0.53 – 0.78) ** 
Education   
 Secondary School 1.73(1.19 – 2.53) ** 
 Vocational School 1.25 (0.84 – 1.85) 
 Bachelor Degree or eq. 0.44 (0.30 – 0.63) ** 
Previous medical travel   
 Experience in medical travel 0.61 (0.37 – 0.98) * 
Sex   
 Male 0.82 (0.62 – 1.12) 
Random Parameters 
Country of Destination Level    
Intercept – Country of 
Destination 
 1.99  
Model Fit indexes 
ICC (intercept)  0.22  
AIC  3336.84 
BIC  3463.95 
Note: ªAll the results are presented as odd ratios with confidence intervals in parentheses * Significant at .05 level. ** 
Significant at .01 level. ICC = Intraclass Correlation Coefficient. AIC = Akaike Information Criterion. BIC = Bayesian 
Information Criterion. It is important to note that AIC and BIC are criteria for model comparison/selection but only 
one multilevel model was tested. These figures cannot be directly interpreted and have no meaning as stand-alone 
indexes but are presented in the event further analyses are done for contrast.  
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Table 2. 
Estimated agreement to travel for medical care for each country. 
 
Country Estimated likelihood of travel 
Germany 80.7% 
United Kingdom 78.5% 
United States of America 59.8% 
New Zealand 58.0% 
Australia 56.1% 
Malta 50.3% 
Portugal 50.0% 
Dubai 46.4% 
Qatar 38.3% 
Singapore 35.7% 
Philippines 22.3% 
Thailand 21.6% 
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